Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Michigan Head Pain and Neurological Institute (MHNI) is a world-renowned tertiary care center and clinical research facility specializing in the treatment of headache and related painful disorders. Founded in 1978 by Dr. Joel Saper, it was the first comprehensive head pain treatment program in the United States and remains a leader in the field of neurology and pain management. The institute utilizes a multidisciplinary approach, integrating neurology, internal medicine, psychology, and physical therapy to treat complex and refractory cases. MHNI's research division is a prolific site for clinical trials, having contributed to the development and FDA approval of nearly every major migraine medication currently on the market. In addition to outpatient services, the institute operates a specialized inpatient program for intensive pain management and detoxification.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Michigan Head Pain and Neurological Institute.